Cedilla Therapeutics Competitors and Similar CompaniesClear all
Clovis Oncology's competitors and similar companies include Vivoryon Therapeutics and Pharmacyclics.
 Clovis Oncology Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents. |  Vivoryon Therapeutics Vivoryon Therapeutics (previously known as Probiodrug) is a precision intervention company specializing in discovering and developing therapies for patients suffering from age-related diseases. |  Pharmacyclics Pharmacyclics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. | |
Founding Date | Founding Date 2009 | Founding Date 1997 | Founding Date 1991 |
Type | Type Public | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations Halle (Saale), DE HQ München, DE | Locations Sunnyvale, US HQ | |
Employees | Employees 4843% increase | Employees 14 | Employees 6551% decrease |
Valuation ($) | Valuation ($) 10.6 m | Valuation ($) 69.8 m | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) $148.8m (FY, 2021) | Revenue (est.) N/A | Revenue (est.) $729.7m (FY, 2014) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods $40.4m (FY, 2014) |
Gross profit | Gross profit N/A | Gross profit €265k (FY, 2025) | Gross profit $689.3m (FY, 2014) |
Net income | Net income ($264.5m) (FY, 2021) | Net income (€8.9m) (FY, 2025) | Net income $86.1m (FY, 2014) |
For sources of this data, please see the company profile
View Company Profiles
Vivoryon Therapeutics
HQ
Halle (Saale), DE
Employees
14
Vivoryon Therapeutics (previously known as Probiodrug) is a precision intervention company specializing in discovering and developing therapies for patients suffering from age-related diseases.
View companyPharmacyclics
HQ
Sunnyvale, US
Pharmacyclics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases.
View company